-31.6%
CLSK vs BBIO
+136.7%
-168.3%
-95.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.8% | -0.1% | +6.9% | +6.8% |
| 7D | +7.7% | -3.2% | +10.9% | +8.6% |
| 30D | +12.2% | -13.6% | +25.8% | +16.5% |
| 3M | -15.5% | +7.2% | -22.7% | -17.5% |
| 6M | +39.3% | +1.5% | +37.9% | +37.8% |
| YTD | +35.1% | -5.3% | +40.4% | +36.0% |
| 1Y | +34.0% | +37.7% | -3.7% | +23.1% |
| 3Y | +226.3% | +153.9% | +72.3% | +150.4% |
| 5Y | +6.4% | +43.9% | -37.5% | -36.8% |
| All | -31.6% | +136.7% | -168.3% | -62.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling